Resectable Non-Small-Cell Lung Cancer trials recruiting in Minnesota

Fewer than 3 recruiting trials found.

All Resectable Non-Small-Cell Lung Cancer trials nationally

Cities in Minnesota

Recruiting trials in Minnesota

• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
  NCT04198766 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Minnesota: Saint Louis Park, Saint Paul